Raimondo, ML; Dagher, L; Papatheodoridis, GV; Rolando, N; Patch, DW; Davidson, BR; ... Burroughs, AK; + view all Raimondo, ML; Dagher, L; Papatheodoridis, GV; Rolando, N; Patch, DW; Davidson, BR; Rolles, K; Burroughs, AK; - view fewer (2003) Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation , 75 (2) 186 - 190. 10.1097/01.TP.0000041702.31262.CD.
Full text not available from this repository.
Calcineurin inhibitors (CNIs) are the first-line immunosuppressive agents administered after liver transplantation, but they cause renal impairment. Two recent randomized trials report cellular rejection and liver graft loss when mycophenolate mofetil (MMF) monotherapy was used as a renal-sparing agent. Our experience with MMF in the same setting but with longer follow-up is described.
|Title:||Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.|
|Keywords:||Adult, Aged, Calcineurin, Chronic Disease, Creatinine, Female, Graft Rejection, Humans, Immunosuppressive Agents, Kidney Diseases, Liver Transplantation, Male, Middle Aged, Mycophenolic Acid|
Archive Staff Only: edit this record